IER5 Is Involved in DNA Double-Strand Breaks Repair In
Total Page:16
File Type:pdf, Size:1020Kb
Int. J. Med. Sci. 2017, Vol. 14 1292 Ivyspring International Publisher International Journal of Medical Sciences 2017; 14(12): 1292-1300. doi: 10.7150/ijms.21510 Research Paper IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells Xin-Ping Yu1, Yu-Mei Wu1, Yang Liu1, Ming Tian1, Jian-Dong Wang1, Ku-Ke Ding2, Teng Ma3, Ping-Kun Zhou3 1. Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, 100006, China; 2. National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing ,100088, China; 3. Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, China. Corresponding author: Yu-Mei Wu, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, 17 Qi-he-lou St, Dongcheng District, Beijing 100006, China. E-mail: [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2017.06.17; Accepted: 2017.09.01; Published: 2017.09.30 Abstract The immediate early response gene 5 (IER5) is a radiation response gene induced in a dose-independent manner, and has been suggested to be a molecular biomarker for biodosimetry purposes upon radiation exposure. Here, we investigated the function of IER5 in DNA damage response and repair. We found that interference on IER5 expression significantly decreased the efficiency of repair of DNA double-strand breaks induced by ionizing radiations in Hela cells. We found that IER5 participates in the non-homologous end-joining pathway of DNA breaks repair. Additionally, we identified a number of potential IER5-interacting proteins through mass spectrometry-based protein assays. The interaction of IER5 protein with poly(ADP-Ribose) polymerase 1 (PARP1) and Ku70 was further confirmed by immunoprecipitation assays. We also found that Olaparib, a PARP1 inhibitor, affected the stability of IER5. These results indicate that targeting of IER5 may be a novel DNA damage response-related strategy to use during cervical cancer radiotherapy or chemotherapy. Key words: cervical cancer; IER5; DNA double strand break repair; ionizing radiation; PARP1; Olaparib. Introduction Cervical cancer is a leading threat to women’s early response gene 5 (IER5), was found to be induced health, especially in developing countries [1]. The by ionizing radiation (IR) in studies using cDNA treatment for cervical cancer includes surgery, microarray technology [9, 10]. radiation, and chemotherapy. Concurrent IER5 belongs to the immediate-early gene chemoradiotherapy has been regarded as the family, and encodes a protein of 327 amino acids, standard treatment of locally advanced cervical mostly located in the cytoplasm [11]. IER5 can be cancer [2-5]. Because of the widespread uptake of induced by growth-promoting and oncogenic signals, screening for the early detection of cervical cancer, its IR and heat shock. IER5 plays a role in cell death rate has declined [1, 6]. However, no significant proliferation, and it inhibits cell proliferation through improvements have been achieved in cervical cancer the reduction of Cdc25B expression, resulting in survival rate over the past three decades [7]. G2/M cell cycle arrest [11, 12]. Additionally, IER5 Therefore, it is necessary to discover new and interacts with protein phosphatase 2A (PP2A) and is effective strategies for a favorable therapeutic involved in the generation of a hypophosphorylated outcome. Specific molecules involved in active form of heat shock factor 1 (HSF1), contributing radiosensitivity have been the focus of many studies to proliferation and survival of cancer cells [13-15]. in recent years [8]. One of such molecules, immediate Previous studies have shown that the expression http://www.medsci.org Int. J. Med. Sci. 2017, Vol. 14 1293 of IER5 in response to radiation response is Mix with gDNA Remover kit (TOYOBO), following dose-independent [16]. IER5 is involved in DNA the manufacturer’s instructions. Quantitative PCR damage repair. Therefore, it has been suggested that (qPCR) was performed with a Bio-Rad iCycler&iQ IER5 can be used as molecular biomarker for Real-time PCR system (Bio-Rad) and a biodosimetry purposes [16, 17]. However, whether fluorescence-labeled SYBR Green real master Mix kit IER5 functions in cervical cancer cellular response to (TIANGEN Biotech [Beijing] Co. LTD). The mRNA radiation is still unclear. primers were as follows: IER5 (forward: In the present study, we report that IER5 is 5’CCGGGAACGTGGCTAACC3’; reverse: involved in the DNA repair process. Specifically, IER5 5’TTCCGTAGGAGTCCCGAGAA3’); β-actin participates in non-homologous end joining (forward: 5’GCGCGGCTACAGCTTCA3’; reverse: (NHEJ)-mediated DNA double strand breaks (DSBs) 5’CTTAATGTCACGCACGATTTCC3’). repair. Additionally, we used immunoprecipitation assays and mass spectrometry (MS) to identify the Plasmids, RNA interference and cell proteins that interact with IER5. Our study has transfection established the foundation to further study the role of The cDNA of IER5 was amplified by RT-PCR IER5 in cervical cancer, and hypothesized its use in from total RNA extracted from Hela cells and cloned cancer therapy. into the pCMV plasmid in frame with the sequence encoding 3×FLAG epitopes (p3×FLAG-IER5-CMV). Materials and methods To specifically knock down gene expression in Hela cells, the following small interfering RNAs (siRNAs) Patient samples and immunohistochemistry were used: native control siRNA (siNC) Human cervical tissue samples were obtained (UUCUCCGAACGUGUCACGUTT), siIER5 from Beijing Biobank of Clinical Resources. The (CCUCAUCAGCAUCUUCGGUUU), si53BP1 collection of human tissue samples was approved and (GAAGGACGGAGUACUAAUATT), siRAD51 supervised by the Ethics Committee of Beijing (GAAGCUAUGUUCGCCAUUATT). The pDR-GFP, Obstetrics and Gynecology Hospital. Thirty-one pEGFP-Pem1-Ad2 and pCherry plasmids and I-SceI cervical cancer tissues and 20 normal cervical tissues had been previously obtained by our laboratory. were obtained. Hela cells were seeded into 6-well plates or 100 Immunohistochemistry was carried out using mm culture plates and cultured in medium without the Ultra-Sensitive S-P kit (Boster Bioscience [Hubei antibiotics; siRNAs or plasmids were transfected into Province, China] Co. LTD), following the cells using Lipofectamine 2000 (Invitrogen), following manufacturer’s instructions. The staining of IER5 was the manufacturer’s recommendations. Cells were scored considering both the percentage of positive harvested 36/48 h after transfection and subjected to cells and intensity of the staining, as described the specified assays. previously [18]. The number of positive cells was counted in at least ten fields for each section and Western blot analysis analyzed with the Image Pro Plus software. Cells were lysed in lysis buffer (Thermo); equal amounts of protein were separated by Cell culture and treatment SDS-polyacrylamide gel electrophoresis (SDS-PAGE) Hela cells were cultured in Dulbecco’s modified and then transferred onto polyvinylidene fluoride Eagle’s medium (Hyclone), supplemented with 10 % membranes. The membranes were blocked with 5 % fetal calf serum (FBS, Sigma), and 100 U/ml penicillin milk in TBST (20 mM Tris-HCl, 500 mM NaCl [pH7.5], and 100 mg/ml streptomycin (Hyclone). Cells were 0.1 % [v/v] Tween 20) for 1 h at room temperature, incubated at 37 °C, in a 5 % CO2 incubator. and incubated with the primary antibodies overnight Cells were irradiated with 60Co γ-rays at a dose at 4 °C. Membranes were then incubated with the rate of 1.98 Gy/min at room temperature. Cells were appropriate secondary antibody for 1 h at room treated with 10 μM Olaparib (Selleck), MG132 temperature, and washed with TBST. Bands were (Merck), or cycloheximide (CHX, Sigma), as indicated; visualized using the Image quant LAS500 system stock solution were prepared in dimethyl sulfoxide (GE). (DMSO ). Antibodies used in this study: anti-IER5 goat polyclonal antibody (Abcam), anti-IER5 rabbit Reverse transcription and quantitative polyclonal antibody (Santa Cruz), anti-GAPDH polymerase chain reaction mouse monoclonal antibody (Zhong Shan Jin Qiao), Total RNA was extracted from cells using TRIzol anti-PARP1 rabbit monoclonal antibody (Santa Cruz), (Invitrogen). Reverse transcription (RT-PCR) was anti-Ku70 mouse monoclonal antibody (Abcam), carried out using the ReverTra Ace qPCR RT Master http://www.medsci.org Int. J. Med. Sci. 2017, Vol. 14 1294 anti-Ku80 rabbit monoclonal antibody (Santa Cruz), Visualization and Integrated Discovery (DAVID) anti-FLAG M2 mouse monoclonal antibody (Sigma), online database was used to analyze the MS report. anti-53BP1 rabbit polyclonal antibody (Santa Cruz), Statistical significance was defined as p < 0.05. anti-RAD51 rabbit polyclonal antibody (Proteintech), anti-γH2AX mouse monoclonal antibody (Millipore), Results anti-Ubiquitinylated proteins mouse monoclonal The expression of IER5 was higher in tumor antibody (Millipore), and anti-PADPR mouse tissues than in normal cervical tissues monoclonal antibody (Abcam). We analyzed the expression of IER5 in 31 Neutral comet assay cervical cancer tissues samples and 20 normal cervical Hela cells were collected at 0 h (mock treated), 10 tissue samples.